Dopaminergic stimulation leads B-cell infiltration into the central nervous system upon autoimmunity
Background Recent evidence has shown dopamine as a major regulator of inflammation. Accordingly, dopaminergic regulation of immune cells plays an important role in the physiopathology of inflammatory disorders. Multiple sclerosis (MS) is an inflammatory disease involving a $ CD4^{+} $ T-cell-driven autoimmune response to central nervous system (CNS) derived antigens. Evidence from animal models has suggested that B cells play a fundamental role as antigen-presenting cells (APC) re-stimulating $ CD4^{+} $ T cells in the CNS as well as regulating T-cell response by mean of inflammatory or anti-inflammatory cytokines. Here, we addressed the role of the dopamine receptor D3 (DRD3), which displays the highest affinity for dopamine, in B cells in animal models of MS. Methods Mice harbouring Drd3-deficient or Drd3-sufficient B cells were generated by bone marrow transplantation into recipient mice devoid of B cells. In these mice, we compared the development of experimental autoimmune encephalomyelitis (EAE) induced by immunization with a myelin oligodendrocyte glycoprotein (MOG)-derived peptide (pMOG), a model that leads to CNS-autoimmunity irrespective of the APC-function of B cells, or by immunization with full-length human MOG protein (huMOG), a model in which antigen-specific activated B cells display a fundamental APC-function in the CNS. APC-function was assessed in vitro by pulsing B cells with huMOG-coated beads and then co-culturing with MOG-specific T cells. Results Our data show that the selective Drd3 deficiency in B cells abolishes the disease development in the huMOG-induced EAE model. Mechanistic analysis indicates that although DRD3-signalling did not affect the APC-function of B cells, DRD3 favours the CNS-tropism in a subset of pro-inflammatory B cells in the huMOG-induced EAE model, an effect that was associated with higher CXCR3 expression. Conversely, the results show that the selective Drd3 deficiency in B cells exacerbates the disease severity in the pMOG-induced EAE model. Further analysis shows that DRD3-stimulation increased the expression of the CNS-homing molecule CD49d in a B-cell subset with anti-inflammatory features, thus attenuating EAE manifestation in the pMOG-induced EAE model. Conclusions Our findings demonstrate that DRD3 in B cells exerts a dual role in CNS-autoimmunity, favouring CNS-tropism of pro-inflammatory B cells with APC-function and promoting CNS-homing of B cells with anti-inflammatory features. Thus, these results show DRD3-signalling in B cells as a critical regulator of CNS-autoimmunity..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
---|---|
Enthalten in: |
Journal of neuroinflammation - 18(2021), 1 vom: 17. Dez. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Prado, Carolina [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Antigen-presenting cells |
---|
Anmerkungen: |
© The Author(s) 2021 |
---|
doi: |
10.1186/s12974-021-02338-1 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR050366335 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR050366335 | ||
003 | DE-627 | ||
005 | 20230509100103.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230507s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s12974-021-02338-1 |2 doi | |
035 | |a (DE-627)SPR050366335 | ||
035 | |a (SPR)s12974-021-02338-1-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Prado, Carolina |e verfasserin |4 aut | |
245 | 1 | 0 | |a Dopaminergic stimulation leads B-cell infiltration into the central nervous system upon autoimmunity |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © The Author(s) 2021 | ||
520 | |a Background Recent evidence has shown dopamine as a major regulator of inflammation. Accordingly, dopaminergic regulation of immune cells plays an important role in the physiopathology of inflammatory disorders. Multiple sclerosis (MS) is an inflammatory disease involving a $ CD4^{+} $ T-cell-driven autoimmune response to central nervous system (CNS) derived antigens. Evidence from animal models has suggested that B cells play a fundamental role as antigen-presenting cells (APC) re-stimulating $ CD4^{+} $ T cells in the CNS as well as regulating T-cell response by mean of inflammatory or anti-inflammatory cytokines. Here, we addressed the role of the dopamine receptor D3 (DRD3), which displays the highest affinity for dopamine, in B cells in animal models of MS. Methods Mice harbouring Drd3-deficient or Drd3-sufficient B cells were generated by bone marrow transplantation into recipient mice devoid of B cells. In these mice, we compared the development of experimental autoimmune encephalomyelitis (EAE) induced by immunization with a myelin oligodendrocyte glycoprotein (MOG)-derived peptide (pMOG), a model that leads to CNS-autoimmunity irrespective of the APC-function of B cells, or by immunization with full-length human MOG protein (huMOG), a model in which antigen-specific activated B cells display a fundamental APC-function in the CNS. APC-function was assessed in vitro by pulsing B cells with huMOG-coated beads and then co-culturing with MOG-specific T cells. Results Our data show that the selective Drd3 deficiency in B cells abolishes the disease development in the huMOG-induced EAE model. Mechanistic analysis indicates that although DRD3-signalling did not affect the APC-function of B cells, DRD3 favours the CNS-tropism in a subset of pro-inflammatory B cells in the huMOG-induced EAE model, an effect that was associated with higher CXCR3 expression. Conversely, the results show that the selective Drd3 deficiency in B cells exacerbates the disease severity in the pMOG-induced EAE model. Further analysis shows that DRD3-stimulation increased the expression of the CNS-homing molecule CD49d in a B-cell subset with anti-inflammatory features, thus attenuating EAE manifestation in the pMOG-induced EAE model. Conclusions Our findings demonstrate that DRD3 in B cells exerts a dual role in CNS-autoimmunity, favouring CNS-tropism of pro-inflammatory B cells with APC-function and promoting CNS-homing of B cells with anti-inflammatory features. Thus, these results show DRD3-signalling in B cells as a critical regulator of CNS-autoimmunity. | ||
650 | 4 | |a Regulatory B lymphocytes |7 (dpeaa)DE-He213 | |
650 | 4 | |a Antigen-presenting cells |7 (dpeaa)DE-He213 | |
650 | 4 | |a Chemokine receptors |7 (dpeaa)DE-He213 | |
650 | 4 | |a Neuroinflammation |7 (dpeaa)DE-He213 | |
650 | 4 | |a Experimental autoimmune encephalomyelitis |7 (dpeaa)DE-He213 | |
650 | 4 | |a Central nervous system homing |7 (dpeaa)DE-He213 | |
700 | 1 | |a Osorio-Barrios, Francisco |4 aut | |
700 | 1 | |a Falcón, Paulina |4 aut | |
700 | 1 | |a Espinoza, Alexandra |4 aut | |
700 | 1 | |a Saez, Juan José |4 aut | |
700 | 1 | |a Yuseff, María Isabel |4 aut | |
700 | 1 | |a Pacheco, Rodrigo |0 (orcid)0000-0001-8057-9806 |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of neuroinflammation |d London : BioMed Central, 2004 |g 18(2021), 1 vom: 17. Dez. |w (DE-627)SPR02908735X |w (DE-600)2156455-3 |x 1742-2094 |7 nnns |
773 | 1 | 8 | |g volume:18 |g year:2021 |g number:1 |g day:17 |g month:12 |
856 | 4 | 0 | |u https://dx.doi.org/10.1186/s12974-021-02338-1 |z kostenfrei |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
951 | |a AR | ||
952 | |d 18 |j 2021 |e 1 |b 17 |c 12 |